Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-15T01:59:45.752Z Has data issue: false hasContentIssue false

Making a C-DIFFerence: Implementation of a prevention collaborative to reduce hospital-onset Clostridioides difficile infection rates

Published online by Cambridge University Press:  26 May 2022

Katelyn A. White*
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Laura E.A. Barnes
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Rachel L. Snyder
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Lucy V. Fike
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
David T. Kuhar
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Ronda L. Cochran
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
*
Author for correspondence: Katelyn A. White, MPH, CIC, Centers for Disease Control and Prevention, Division of Healthcare Quality Promotion, 1600 Clifton Road NE, Mailstop H16-3, Atlanta, GA 30333. E-mail: wwg6@cdc.gov

Abstract

Objective:

To assist hospitals in reducing Clostridioides difficile infections (CDI), the Centers for Disease Control and Prevention (CDC) implemented a collaborative using the CDC CDI prevention strategies and the Targeted Assessment for Prevention (TAP) Strategy as foundational frameworks.

Setting:

Acute-care hospitals.

Methods:

We invited 400 hospitals with the highest cumulative attributable differences (CADs) to the 12-month collaborative, with monthly webinars, coaching calls, and deployment of the CDC CDI TAP facility assessments. Infection prevention barriers, gaps identified, and interventions implemented were qualitatively coded by categorizing them to respective CDI prevention strategies. Standardized infection ratios (SIRs) were reviewed to measure outcomes.

Results:

Overall, 76 hospitals participated, most often reporting CDI testing as their greatest barrier to achieving reduction (61%). In total, 5,673 TAP assessments were collected across 46 (61%) hospitals. Most hospitals (98%) identified at least 1 gap related to testing and at least 1 gap related to infrastructure to support prevention. Among 14 follow-up hospitals, 64% implemented interventions related to infrastructure to support prevention (eg, establishing champions, reviewing individual CDIs) and 86% implemented testing interventions (eg, 2-step testing, testing algorithms). The SIR decrease between the pre-collaborative and post-collaborative periods was significant among participants (16.7%; P < .001) but less than that among nonparticipants (25.1%; P < .001).

Conclusions:

This article describes gaps identified and interventions implemented during a comprehensive CDI prevention collaborative in targeted hospitals, highlighting potential future areas of focus for CDI prevention efforts as well as reported challenges and barriers to prevention of one of the most common healthcare-associated infections affecting hospitals and patients nationwide.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Hospital Characteristics Among Collaborative Participant Hospitals (n = 76) and Hospitals That Met the Recruitment Criteria but Did Not Participate (Nonparticipants, n = 306).

Figure 1

Table 2.Qualitative Information Provided by Participants Throughout the Collaborative, Categorized to Align With the Clostridioides difficile (CDI) Prevention Strategies

Figure 2

Table 3.Clostridioides difficile Infection (CDI) Targeted Assessment for Prevention (TAP) Facility Assessment Questions for which at Least 50% of Hospitals Identified a Gapa

Figure 3

Table 4.Environmental Services (EVS) Assessment Questions for which at Least 50% of Hospitals Identified a Gapa

Figure 4

Fig. 1.Standardized infection ratios (SIRs) by quarter for Collaborative participant hospitals (n = 76) and hospitals that met the recruitment criteria but did not participate (nonparticipants, n = 306).

Supplementary material: PDF

White et al. supplementary material

White et al. supplementary material

Download White et al. supplementary material(PDF)
PDF 142.2 KB